Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maheboob Basade"'
Autor:
Purvish Mahendra Parikh, Shyam Aggarwal, Ghanashyam Biswas, Seema Gulia, Vivek Agarwala, Maheboob Basade, P.N. Mohapatra, Krishna Muddu Vamshi, Arun Warrier, Krishna Prasad, Partha Roy, M.V. Chandrakant, Hemant Malhotra, Sachin Hingmire, Davinder Paul, Vashista Maniar, Alok Gupta, Soumya S. Panda, Aseem Samar, Nitesh Rohatgi, Satya Dattatreya, Manjunath Krishnamurthy, Raja Thirumalairaj
Publikováno v:
South Asian Journal of Cancer, Vol 12, Iss 02, Pp 093-099 (2023)
Externí odkaz:
https://doaj.org/article/a0225a2bc6da4d9395ddb2348d2e3bb2
Autor:
Purvish M. Parikh, Amish Vora, Rajan Yadav, Akhil Kapoor, Tarini Sahoo, Senthil Rajappa, Govind Babu Kanakashetty, M. Vamshi Krishna, Ghanashyam Biswas, Ankur Bahl, Nikhil Ghadyalpatil, Thirumalairaj Raja, Jyoti Bajpai, Amol Akhade, Randeep Singh, Shyam Aggarwal, Maheboob Basade, S.H. Advani
Publikováno v:
South Asian Journal of Cancer, Vol , Iss
Externí odkaz:
https://doaj.org/article/0db26f0ba56a4d05baf8774a1efb2405
Autor:
Maheboob Basade
Publikováno v:
Oncology.
Not applicable (Letters should contain 500 words in total and no abstract)
Autor:
Jean-Marc Maurel, Maria Belen Tamayo, Rosario Pitargue, Annielyn Beryl Ong-Cornel, Piyush Mehta, Doudou Diouf, Chetan Deshmukh, Maheboob Basade, Salif Balde, Eunice Adanza-Cutillar, Shaheenah Dawood
Publikováno v:
Oncology.
Letter (no abstract)
Autor:
Mohan Bajranglal Agarwal, Manthanathu Joseph John, Punit Jain, Ashok Kumar Vaid, Ajay Bapna, Maheboob Basade, Palanki Satya Dattatreya, Anupam Chakrapani, Vijay Ramanan, R. Varadarajan, Murali Subramanian, Chirag Aniruddha Shah, Narayanakutty Warrier, Subhaprakash Sanyal, Tyavanagi Shankarmurthy Ashwin, Nagendra Ramanjinappa
Publikováno v:
Indian Journal of Medical and Paediatric Oncology.
Management of chronic myeloid leukemia (CML) has been transformed by the use of tyrosine kinase inhibitors (TKIs). Presently in India, five TKIs are approved for the management of CML with distinct safety profiles. The selection of TKIs for chronic p
Autor:
Maheboob Basade, Akshata Mane
Publikováno v:
Indian journal of cancer. 58(1)
Metastatic colorectal cancer (mCRC) accounts for over 20% of CRC cases and is associated with a poor prognosis. Irinotecan is an important first- and second-line chemotherapy option for mCRC. In this review, we summarize the clinical efficacy and saf
Autor:
Hemant Malhotra, P N Mahapatra, Chanchal Goswami, Chirag Shah, Pavithran Keechilat, Suresh H. Advani, T. P. Sahoo, Maheboob Basade, Raju Titus Chacko
Publikováno v:
Indian journal of cancer. 54
Advanced nonsmall cell lung cancer (NSCLC) treatment is primarily based on platinum-based chemotherapy. Although epidermal growth factor receptor (EGFR) targeting has shifted the treatment paradigm toward personalized tyrosine kinase inhibitors (TKIs
Autor:
Maheboob Basade, SC Gulati
Publikováno v:
The Lancet. 351:1733